Exagen Inc. XGN Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$20.17M-1.1% | -$19.95M-4.8% | -$19.04M-12.1% | -$16.98M-9.5% | -$15.51M-2.6% | ||
| $2.4M+11.0% | $2.16M+14.4% | $1.89M+24.9% | $1.51M-7.2% | $1.63M-7.7% | ||
| —— | —— | —— | -$15.73M-3.0% | -$15.27M-12.0% | ||
| $756K+17.9% | $641K-13.7% | $743K+20.8% | $615K+13.5% | $542K+5.2% | ||
| -$747K-19.3% | -$626K+15.1% | -$737K-21.0% | -$609K-13.6% | -$536K-4.1% | ||
| $653K+10.3% | $592K+38.6% | $427K+61.1% | $265K+531% | $42K— | ||
| $24.82M0.0% | $24.82M+0.9% | $24.6M+14.3% | $21.53M+3,534% | -$627K+5.4% | ||
| —— | —— | $13.62M+145% | $5.55M+135% | -$16.07M-11.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Exagen Inc. generate?
- Exagen Inc. (XGN) generated -$27.0M in operating cash flow over the trailing twelve months.
- What is Exagen Inc.'s free cash flow?
- After $756.0K of capital expenditures, Exagen Inc.'s free cash flow was -$27.6M over the trailing twelve months, down 96.9% year over year.
- Where does Exagen Inc.'s cash flow data come from?
- Every line is extracted from Exagen Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
